About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight Blogs

Talking Reference Data with Andrew Delaney: How to Profit from LEI

Subscribe to our newsletter

As predicted here, the Summer of LEI continues unabated. Returning from a couple of weeks in the Mediterranean – now on a diet – I read with interest our own Sarah Underwood’s account of the Financial Stability Board’s inaugural Legal Entity Identifier (LEI) Private Sector Preparatory Group (PSPG), and settled down to catch up on the latest supply-side missive on the topic: this time from Thomson Reuters.

You can read global head of legal entity content Tim Lind’s paper – titled Legal Entity Data: Mapping the Corporate Genome – by downloading it for free below. What struck me about the piece – aside from Tim’s usual rigorous treatment of the topic – was its perhaps-contrarian, bright outlook for those practitioners embracing the standard.

Lind’s paper is striking in the way that it places the LEI at the centre of the universe. His words: “We are entering a new phase in the evolution of financial data and a potential renaissance in the approach to risk management. Legal entity data will be the core building block of this renaissance.” Stirring stuff.

But whereas many industry commentators have focused on the ‘stick’ element of the need for a standard entity identifier – how failing to settle on an agreed approach will result in dire consequences of Lehman-like proportions – Lind’s paper takes a stab at identifying the ‘carrot’.

“It would be a mistake,” he writes, “to overlook the potential predictive value of legal entity data in terms of discovering revenue opportunity and supporting investment and trading positions.” In other words, this is not about mopping up after the act; it’s about pre-trade analysis of a sort.

Lind goes on to illustrate this potential through the analogy of the human genome. It’s one we’ve pondered in the past, especially since our old boss, Dennis Waters, decided to ditch the familiar world of financial technology (he sold us to Risk Magazine for $13 million) to embrace all things genome: take a look at www.genomeweb.com if this floats your boat.

In Lind’s view, the science of the human genome – and how relationships between component parts can help predict, say, how vulnerable an organism is to a specific disease – illustrates how important definition and documentation is to the science of prediction in financial markets: “To advance our understanding of credit and market risk, we first must map and document the core reference data of the corporate genome.”

Pre-Lehman and beyond, “Many firms struggled with how they uniquely identify an entity, its core attributes, their corporate hierarchy, and how to link entities to outstanding positions, transactions and other data used to assess counterparty and credit risk.” I think you get where he is going with this.

Lind’s paper goes on to talk about how various regulations are driving the need for something – something – to meet this need, and offers Thomson Reuters’ vision for creating an entity- rather than security-centric view of the world. He provides a useful check-list of the adjacent data sets that Thomson Reuters believes legal entities should link to: something, surely, to cut out and keep, and possibly stick to the fridge with a magnet (or maybe not).

Subscribe to our newsletter

Related content

WEBINAR

Upcoming Webinar: How to organise, integrate and structure data for successful AI

25 September 2025 10:00am ET | 3:00pm London | 4:00pm CET Duration: 50 Minutes Artificial intelligence (AI) is increasingly being rolled out across financial institutions, being put to work in applications that are transforming everything from back-office data management to front-office trading platforms. The potential for AI to bring further cost-savings and operational gains are...

BLOG

Data Usage Rights Patent is Music to the Ears of VendEx Boss

Richard Clements has a talent for explaining highly technical concepts in ways that make them sound as easy as listening to your favourite song. Which is apt, considering that the chief executive of VendEx, a vendor and data cataloguing technology provider, explains his company’s latest innovation with a guitar perched on a stand beside him....

EVENT

RegTech Summit London

Now in its 9th year, the RegTech Summit in London will bring together the RegTech ecosystem to explore how the European capital markets financial industry can leverage technology to drive innovation, cut costs and support regulatory change.

GUIDE

AI in Capital Markets: Practical Insight for a Transforming Industry – Free Handbook

AI is no longer on the horizon – it’s embedded in the infrastructure of modern capital markets. But separating real impact from inflated promises requires a grounded, practical understanding. The AI in Capital Markets Handbook 2025 provides exactly that. Designed for data-driven professionals across the trade life-cycle, compliance, infrastructure, and strategy, this handbook goes beyond...